Stock screenerAll disclosures →
EDGAR →
SLDB
Conviction 86HealthcareScan · Fri, Aug 7, 2026SLDB$8.38-3.79%
ResistanceSupportVol 14Vol MA14 1.13M
May 8May 27Jun 15Jul 2Jul 22Aug 7
Price8.38
Change-3.79%
Gap-0.63%
Rel volume3.20×
Avg volume1.12M
Avg $ vol9.52M
SMA 208.52
SMA 508.46
SMA 2006.86
Price vs 50-1.00%
Price vs 200+22.23%
MA stackmixed
50/200 cross—
Supertrenddown · 9.43
RSI (14)47
MACD hist0.00
MACD crossbull · 0d
Stoch %K / %D50 / 67
ADX (14)19
+DI / −DI27 / 25
RSI divergence—
MACD divergence—
ATR %+6.32%
ADR %5.46%
52w high11.15
52w low3.93
From 52w high-24.84%
Above 52w low+113.23%
New 52w highNo
SqueezeOff
Bollinger width27.08%
%B0.44
Donchian pos28.08%
Donchian high10.25
Donchian low7.65
AVWAP (52w high)9.19
vs AVWAP high-8.83%
AVWAP (52w low)7.24
vs AVWAP low+15.78%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d3.20×
Avg vol (14d)1.13M
Avg vol (20d)1.12M
Avg $ vol (20d)9.52M
Market cap898.55M
RS 3m (vs SPY)+16.24%
RS 6m (vs SPY)+21.58%
RS line new highNo
Trend template7/8
Technical rank57.6
1 week+3.97%
1 month-24.78%
3 months+18.53%
6 months+34.51%
1 year+28.73%
YTD+53.76%
P/E-7.67
P/B2.40
P/S111.01
P/FCF-5.71
EPS-1.99
Div yield—
ROE-31.34%
ROA-27.87%
Debt/Eq—
Current13.82
EV/EBITDA-4.16
Gross margin—
Net margin—
Rev growth-40.57%
EPS growth-56.72%
Price target16.75
Target upside99.88%
Analyst ratingBuy
Institutional110.50%
Ent. value739.15M
Revenue0
Net income-17.98M
Gross profit—
Free cash flow-157.44M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out98.45M
Employees121
ListedThu, Jan 25, 2018
Free float66.77M
Float %67.9%
Short interest17.67M
Days to cover11.2d
Short volume51.5%
Squeeze score88 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.38 vs −$0.43
Last surprise+11.6% beat
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank57.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.62
Support7.30
Days since event—
Candle confirm—
News sentiment—
Financials as of Thu, Sep 30, 2021 · quarterly.
Congress activity
Disclosed STOCK Act trades in SLDB
No recent disclosed trades by Congress in SLDB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SLDB · 7 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SMITH IAN F Director · Common Stock · 2026-07-02 | Exercise | 3.44K | — | 2026-07-02 | 2026-07-07 |
SMITH IAN F Director · Restricted Stock Units · 2026-07-02 | Exercise | 3.44K | — | 2026-07-02 | 2026-07-07 |
Tan Kevin CFO & Treasurer · Restricted Stock Units · 2026-01-29 | Grant | 56.65K | $0 | 2026-01-29 | 2026-04-21 |
Howton David T Chief Operating Officer · Restricted Stock Units · 2026-01-29 | Grant | 79.34K | $0 | 2026-01-29 | 2026-04-21 |
Brooks Gabriel Chief Medical Officer · Restricted Stock Units · 2026-01-29 | Grant | 58.85K | $0 | 2026-01-29 | 2026-04-21 |
Hanrahan Jessie Chief Regulatory Officer · Restricted Stock Units · 2026-01-29 | Grant | 54.92K | $0 | 2026-01-29 | 2026-04-21 |
Cumbo Alexander President and CEO · Restricted Stock Units · 2026-01-29 | Grant | 169.4K | $0 | 2026-01-29 | 2026-04-21 |
Herzich Paul Chief Technology Officer · Restricted Stock Units · 2026-01-29 | Grant | 54.92K | $0 | 2026-01-29 | 2026-04-21 |
SEC filings
EDGAR filings in SLDB · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.